BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 23279867)

  • 21. Mitochondrial disruption and DNA fragmentation in Trypanosoma cruzi induced by naphthoimidazoles synthesized from beta-lapachone.
    Menna-Barreto RF; Corrêa JR; Pinto AV; Soares MJ; de Castro SL
    Parasitol Res; 2007 Sep; 101(4):895-905. PubMed ID: 17546464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new series of heteroleptic oxidovanadium(IV) compounds with phenanthroline-derived co-ligands: selective Trypanosoma cruzi growth inhibitors.
    Fernández M; Varela J; Correia I; Birriel E; Castiglioni J; Moreno V; Costa Pessoa J; Cerecetto H; González M; Gambino D
    Dalton Trans; 2013 Sep; 42(33):11900-11. PubMed ID: 23787783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological evaluation of novel 2,3-disubstituted quinoxaline derivatives as antileishmanial and antitrypanosomal agents.
    Cogo J; Kaplum V; Sangi DP; Ueda-Nakamura T; Corrêa AG; Nakamura CV
    Eur J Med Chem; 2015 Jan; 90():107-23. PubMed ID: 25461316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New antiprotozoal agents: their synthesis and biological evaluations.
    Upadhayaya RS; Dixit SS; Földesi A; Chattopadhyaya J
    Bioorg Med Chem Lett; 2013 May; 23(9):2750-8. PubMed ID: 23518280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis and biological evaluation of sulfur-containing 1,1-bisphosphonic acids as antiparasitic agents.
    Recher M; Barboza AP; Li ZH; Galizzi M; Ferrer-Casal M; Szajnman SH; Docampo R; Moreno SN; Rodriguez JB
    Eur J Med Chem; 2013 Feb; 60():431-40. PubMed ID: 23318904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis and biological evaluation of quinazoline derivatives as anti-trypanosomatid and anti-plasmodial agents.
    Mendoza-Martínez C; Correa-Basurto J; Nieto-Meneses R; Márquez-Navarro A; Aguilar-Suárez R; Montero-Cortes MD; Nogueda-Torres B; Suárez-Contreras E; Galindo-Sevilla N; Rojas-Rojas Á; Rodriguez-Lezama A; Hernández-Luis F
    Eur J Med Chem; 2015; 96():296-307. PubMed ID: 25899334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molluscicidal and trypanocidal activities of lapachol derivatives.
    Santos AF; Ferraz PA; de Abreu FC; Chiari E; Goulart MO; Sant'Ana AE
    Planta Med; 2001 Feb; 67(1):92-3. PubMed ID: 11270734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospects of an alternative treatment against Trypanosoma cruzi based on abietic acid derivatives show promising results in Balb/c mouse model.
    Olmo F; Guardia JJ; Marin C; Messouri I; Rosales MJ; Urbanová K; Chayboun I; Chahboun R; Alvarez-Manzaneda EJ; Sánchez-Moreno M
    Eur J Med Chem; 2015 Jan; 89():683-90. PubMed ID: 25462275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quinoxaline derivatives as potential antitrypanosomal and antileishmanial agents.
    Cogo J; Cantizani J; Cotillo I; Sangi DP; Corrêa AG; Ueda-Nakamura T; Filho BPD; Martín JJ; Nakamura CV
    Bioorg Med Chem; 2018 Aug; 26(14):4065-4072. PubMed ID: 30100019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The evaluation of quinonoid compounds against Trypanosoma cruzi: synthesis of imidazolic anthraquinones, nor-beta-lapachone derivatives and beta-lapachone-based 1,2,3-triazoles.
    da Silva EN; Guimarães TT; Menna-Barreto RF; Pinto Mdo C; de Simone CA; Pessoa C; Cavalcanti BC; Sabino JR; Andrade CK; Goulart MO; de Castro SL; Pinto AV
    Bioorg Med Chem; 2010 May; 18(9):3224-30. PubMed ID: 20378360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 2-Phenylaminonaphthoquinones and related compounds: synthesis, trypanocidal and cytotoxic activities.
    Sieveking I; Thomas P; Estévez JC; Quiñones N; Cuéllar MA; Villena J; Espinosa-Bustos C; Fierro A; Tapia RA; Maya JD; López-Muñoz R; Cassels BK; Estévez RJ; Salas CO
    Bioorg Med Chem; 2014 Sep; 22(17):4609-20. PubMed ID: 25127463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and in vitro antiprotozoal activities of water-soluble, inexpensive 3,7-bis(dialkylamino)phenoxazin-5-ium derivatives.
    Ge JF; Arai C; Kaiser M; Wittlin S; Brun R; Ihara M
    J Med Chem; 2008 Jun; 51(12):3654-8. PubMed ID: 18476684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis and evaluation of 2,4-diaminoquinazolines as inhibitors of trypanosomal and leishmanial dihydrofolate reductase.
    Khabnadideh S; Pez D; Musso A; Brun R; Pérez LM; González-Pacanowska D; Gilbert IH
    Bioorg Med Chem; 2005 Apr; 13(7):2637-49. PubMed ID: 15755663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triclosan-caffeic acid hybrids: Synthesis, leishmanicidal, trypanocidal and cytotoxic activities.
    Otero E; García E; Palacios G; Yepes LM; Carda M; Agut R; Vélez ID; Cardona WI; Robledo SM
    Eur J Med Chem; 2017 Dec; 141():73-83. PubMed ID: 29028533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro screening of 2-(1H-imidazol-1-yl)-1-phenylethanol derivatives as antiprotozoal agents and docking studies on Trypanosoma cruzi CYP51.
    De Vita D; Moraca F; Zamperini C; Pandolfi F; Di Santo R; Matheeussen A; Maes L; Tortorella S; Scipione L
    Eur J Med Chem; 2016 May; 113():28-33. PubMed ID: 26922226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strategies towards potent trypanocidal drugs: Application of Rh-catalyzed [2 + 2 + 2] cycloadditions, sulfonyl phthalide annulation and nitroalkene reactions for the synthesis of substituted quinones and their evaluation against Trypanosoma cruzi.
    Wood JM; Satam NS; Almeida RG; Cristani VS; de Lima DP; Dantas-Pereira L; Salomão K; Menna-Barreto RFS; Namboothiri INN; Bower JF; da Silva Júnior EN
    Bioorg Med Chem; 2020 Aug; 28(15):115565. PubMed ID: 32631558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological evaluation of 1-amino-1,1-bisphosphonates derived from fatty acids against Trypanosoma cruzi targeting farnesyl pyrophosphate synthase.
    Szajnman SH; Ravaschino EL; Docampo R; Rodriguez JB
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4685-90. PubMed ID: 16143525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenyl substitution of furamidine markedly potentiates its anti-parasitic activity against Trypanosoma cruzi and Leishmania amazonensis.
    De Souza EM; Lansiaux A; Bailly C; Wilson WD; Hu Q; Boykin DW; Batista MM; Araújo-Jorge TC; Soeiro MN
    Biochem Pharmacol; 2004 Aug; 68(4):593-600. PubMed ID: 15276066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of 9-hydroxy-α- and 7-hydroxy-β-pyran naphthoquinones on Trypanosoma cruzi and structure-activity relationship studies.
    da Rochaa DR; de Souza AM; de Souza AC; Castro HC; Rodrigues CR; Menna-Barreto RF; de Castro SL; Ferreira VF
    Med Chem; 2014; 10(6):564-70. PubMed ID: 24372389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Norfloxacin Zn(II)-based complexes: acid base ionization constant determination, DNA and albumin binding properties and the biological effect against Trypanosoma cruzi.
    Gouvea LR; Martins DA; Batista Dda G; Soeiro Mde N; Louro SR; Barbeira PJ; Teixeira LR
    Biometals; 2013 Oct; 26(5):813-25. PubMed ID: 23897315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.